Senior Advisor in R&D GlaxoSmithKline plc Rockville, Maryland
I will talk about Adjuvant Systems and how AS03 has been used in the GSK response to the COVID pandemic. In addition, I will summarize our efforts to develop vaccines using self amplifying RNA (SAM).
Understand the response of GSK, a large vaccine manufacturer, to the COVID-19 pandemic and appreciate the potential role of vaccine adjuvants in the solution.
Understand that there are several different kinds of RNA that might be used to create next generation vaccines, including a self amplifying RNA approach, which I will compare and contrast with the others.
Understand the role of formulation science in vaccine development
Appreciate how adjuvants can contribute to the development of many vaccines